Collegium Pharmaceutical (COLL) PT Lowered to $36 at Piper Sandler
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $23.53 -0.72%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $36.00 (from $37.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- ADARx Pharmaceuticals files for proposed IPO
- Starlo to acquire Mexico silver project in reverse takeover deal
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
